Supplementary Table 3 from Prognostic Biomarkers in Phase II Trial of Cetuximab-Containing Induction and Chemoradiation in Resectable HNSCC: Eastern Cooperative Oncology Group E2303

Autor:	Arlene A. Forastiere, Harold J. Wanebo, David L. Rimm, Barbara A. Burtness, Efstratios K. Kosmidis, Maria Vassilakopoulou, Eirini Pectasides, Ju-Whei Lee, Amanda Psyrri
Rok vydání:	2023
DOI:	10.1158/1078-0432.22455212.v1
Popis:	PDF file - 67K, Odds Ratio and Hazard Ratio (with 95% Confidence Interval) with A Unit Increase in the Form of log10 Transformation in AQUA Scores by Biomarker.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03aee9bef0ccbacaf8393056cb7f7104 https://doi.org/10.1158/1078-0432.22455212.v1 Zobrazit plný text záznamu